REPLIGEN (RGEN) Covered Calls

REPLIGEN covered calls A biopharmaceutical company, focused primarily on the development of novel therapeutics for radiology and neuropsychiatry.

You can sell covered calls on REPLIGEN to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for RGEN (prices last updated Fri 4:16 PM ET):

REPLIGEN (RGEN) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
54.01 +0.85 18.00 55.35 237K 98 2.3B
Covered Calls For REPLIGEN (RGEN)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Oct 19 55 0.35 55.00 0.0% 0.0%
Nov 16 55 1.90 53.45 2.9% 29.4%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Repligen Corp. is a life sciences company, which focuses on the development, production and commercialization of products used in the process of manufacturing biological drugs. The company also manufactures Protein A, a critical reagent used to separate and purify monoclonal antibody therapeutics. The company has developed and markets a series of OPUS line of pre-packed plug-and-play chromatography columns used for biologics purification and sells test kits to ensure final product quality. Repligen was founded by Alexander Rich in May 1981 and is headquartered in Waltham, MA.